ArticleInternational journal of dermatology2026
European Dermatologists' Perception and Awareness of Teledermatology Use: Results From an International Survey Promoted by the EADV Teledermatology Task Force.
Article in International journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editor's Highlights-September 2026.International journal of dermatology · 2026Article
- Navigating Teledermatology in the Post-COVID Era.International journal of dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSince the COVID pandemic, there has been an increase in teledermatology (TD) and teledermoscopy (TDS) use. However, no specific data on technical and bureaucratic issues has been collected in Europe to date. We aimed to investigate the real-life knowledge, perceptions, and needs of European dermatologists. MATERIALS AND
methodsAn anonymous survey was shared by email with European dermatologists from September 2024 to June 2025, consisting of four sections and 26 questions.
resultsThe interviewed dermatologists (252) practicing TD more frequently worked in a public hospital, were middle-aged (35-49 years), and had an average of 18 years of experience as a specialist. Only one out of three was aware of the existence of specific guidelines/position statements in their countries, while most dermatologists highlighted the absence of specific IT systems/software recommended by their hospitals/authorities. Most dermatologists (42%) use TD intermittently, while daily use is still limited (15%), especially for chronic inflammatory diseases and skin tumors. The most common applications are "triage and screening" (22%), "assisted diagnosis from another specialist" (20%) and "image analysis and interpretation" (18% of cases). The main objectives are to reduce waiting lists and improve the organization of work schedules. The use of TDS is receiving growing interest compared to the past, with 66% of dermatologists using TDS with varying frequencies and reporting a discrete improvement in clinical outcomes related to both diagnosis and management. DISCUSSION: Understanding the current state of adoption and reluctance toward TD/TDS is fundamental for designing adequate interventions and developing recommendations on specific issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.